A New Treatment for Diabetic Retinopathy
The FDA recently approved Lucentis for use of diabetic retinopathy. Pharmacist and certified diabetes educator Sam Grossman talks about the clinical trial results for the new drug and considerations of how people with the complication may want to consider talking to their provider about it.